v2.4.0.6
Note 3 - Summary of Significant Accounting Policies (Detail) - Basic and diluted weighted average shares outstanding: (USD $)
 3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Net loss attributable to Bluefly, Inc. stockholders (in Dollars) $ (5,680,000) [1],[2],[3],[4] $ (6,277,000) [1],[2],[3],[4] $ (4,949,000) [1],[2],[3],[4] $ (7,870,000) [1],[2],[3],[4] $ (6,180,000) [1],[2],[5] $ (2,494,000) [1],[2],[5] $ (1,032,000) [1],[2],[5] $ (1,278,000) [1],[2],[5] $ 269,000 [1] $ (2,077,000) [1] $ (724,000) [1] $ (1,501,000) [1] $ (24,776,000) $ (10,984,000) $ (4,033,000)
Weighted average common shares outstanding (basic) 28,576,612 [1],[6] 28,576,612 [1],[6] 28,576,612 [1],[6] 28,523,237 [1],[6] 28,284,268 [1],[6],[7] 25,530,899 [1],[6] 24,611,736 [1],[6] 24,605,199 [1],[6] 24,598,811 [1],[6] 24,598,151 [1],[6] 24,597,254 [1],[6] 20,896,437 [1],[6] 28,563,341 25,767,483 23,685,338
Stock option awards and warrants(1)(2)                            [8],[9]    [8],[9]    [8],[9]
Restricted stock awards(1)                            [8]    [8]    [8]
Rho Notes(1)                            [8]    [8]    [8]
Weighted average common shares outstanding (diluted) 28,576,612 [1],[6] 28,576,612 [1],[6] 28,576,612 [1],[6] 28,523,237 [1],[6] 28,284,268 [1],[6],[7] 25,530,899 [1],[6] 24,611,736 [1],[6] 24,605,199 [1],[6] 24,724,658 [1],[6] 24,598,151 [1],[6] 24,597,254 [1],[6] 20,896,437 [1],[6] 28,563,341 25,767,483 23,685,338
[1] Quarterly amounts may not sum to the annual amounts due to rounding.
[2] These amounts exclude net losses attributable to the non-controlling interest in Eyefly LLC.
[3] These amounts include operating expenses attributable to EVT Acquisition Co., LLC.
[4] These amounts include net sales, cost of sales and operating expenses attributable to the Company's controlling interest in Eyefly LLC through October 25, 2012.
[5] This amount, for the fourth quarter of 2011, includes $1.2 million of bad debt expense (which is included as part of general and administrative expenses) related to (a) a write off of $475,000, which the Company was unable to collect in its entirety and (b) an increase in its allowance for doubtful accounts of $725,000 related to the entire remaining balance of the trade receivable. This allowance for doubtful accounts was necessary as the trade receivable was unsecured and the amount that the Company may ultimately recover is not presently determinable.
[6] For years that the Company has incurred losses, and as a result of losses incurred by the Company, all potentially dilutive securities are anti-dilutive and accordingly, basic and diluted weighted average common shares outstanding are equal for the periods presented.
[7] Weighted average common shares outstanding (basic and diluted) increased to 28,284,268 as a result of the September 2011 financing.
[8] As of December 31, 2012, 2011 and 2010, respectively, the Company had weighted average shares of the following potentially dilutive securities that were excluded from the computation of net loss per common share attributable to Bluefly, Inc. stockholders as the effects would be anti-dilutive: Stock option awards and warrants 59,770 90,973 3,873 Restricted stock awards 8,904 -- 11,529 Rho Notes 570,439 -- --
[9] Under the treasury-stock method, the Company excluded all stock option awards and warrants from the computation of weighted average shares as a result of the average market price of the Company's Common Stock being greater than the exercise price of the stock option awards and warrants.